DF, Â., HJ, C., M, S., K, S., F, M., D, S., & F, S. (2026). Clinical Effectiveness of IncobotulinumtoxinA Using a Standardized Protocol in the Management of Myogenous Temporomandibular Disorders: A 12-Month Retrospective Study. Toxins, 18(5), . https://doi.org/10.3390/toxins18050220
Chicago Style (17th ed.) CitationDF, Ângelo, Cardoso HJ, Sarkis M, Santos K, Maffia F, Sanz D, and Salvado F. "Clinical Effectiveness of IncobotulinumtoxinA Using a Standardized Protocol in the Management of Myogenous Temporomandibular Disorders: A 12-Month Retrospective Study." Toxins 18, no. 5 (2026). https://doi.org/10.3390/toxins18050220.
MLA (9th ed.) CitationDF, Ângelo, et al. "Clinical Effectiveness of IncobotulinumtoxinA Using a Standardized Protocol in the Management of Myogenous Temporomandibular Disorders: A 12-Month Retrospective Study." Toxins, vol. 18, no. 5, 2026, https://doi.org/10.3390/toxins18050220.